Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study

Table 4

Data of patients (Pt) at baseline (T₀) and after the treatment (T₁): multiple myeloma (MM); chemotherapy (CT), corticosteroids use (CST), and BRONJ stage according to SICMF-SIPMO staging system and presence of bone status (H= healed; R= reduction; NR= no reduction; E= exposed bone; NE= nonexposed bone).

Pt

Sex

Age

Cancer

Bps

Bps duration (mo)

CT

CST

Affected Jaw

Stage T0

Stage T1

Bone Status T0

Bone Status T1

Output

1

M

72

Prostate

Zoledronate

24

No

No

Upper

I B

I A

E

E

R

2

F

72

MM

Zoledronate

12

Yes

No

Lower

I B

I A

E

E

R

3

F

89

MM

Zoledronate

18

Yes

Yes

Lower

II B

H

E

NE

H

4

F

69

Breast

Zoledronate

36

Yes

No

Lower

I B

H

E

NE

H

5

F

80

MM

Zoledronate

60

Yes

No

Lower

I B

I A

NE

NE

R

6

F

74

Breast

Zoledronate

24

No

No

Lower

II B

II A

NE

NE

R

7

F

77

Breast

Zometa + Ibandronate

96

No

No

Lower

I B

H

E

NE

H

8

M

77

Prostate

Zoledronate

26

Yes

No

Lower

II A

II A

E

E

NR

9

F

70

MM

Zoledronate

18

No

No

Lower

I B

I A

E

NE

R

10

M

72

Prostate

Zoledronate

4

No

Yes

Lower

II A

II A

E

E

NR